Findings from a phase I trial (NCT04183166) evaluating TG4050, a neoantigen therapeutic vaccine, in patients with operable, ...
Techno-Science.net on MSN
A method to produce anti-cancer killer cells en masse
Natural killer cells, or NK cells, are elements of the immune system capable of rapidly locating and destroying cancerous or ...
A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results